Pancreatic Cancer Research

ResearcherCalifornia State University, FresnoActive in the last 2 years

Eric N. Aguilar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9784-1150; OpenAlex author ID A5088861880. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

  1. Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6. Co-author DOI 10.1158/1535-7163.mct-23-0868↗
  2. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer. First author DOI 10.1021/acs.molpharmaceut.2c00203↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Anthony Hollingsworth · 2 shared papers, 2022–2024 · strength 0.32
  2. Christabelle Rajesh · 1 shared paper, 2024 · strength 0.17
  3. Thomas C. Caffrey · 1 shared paper, 2024 · strength 0.17
  4. Satish Sagar · 1 shared paper, 2024 · strength 0.17
  5. Paul M. Grandgenett · 1 shared paper, 2024 · strength 0.17
  6. Prakash Radhakrishnan · 1 shared paper, 2024 · strength 0.17
  7. Geoffrey A. Talmon · 1 shared paper, 2022 · strength 0.15
  8. Madeline T. Olson · 1 shared paper, 2022 · strength 0.15
  9. Kathryn M. Muilenburg · 1 shared paper, 2022 · strength 0.15
  10. Aaron M. Mohs · 1 shared paper, 2022 · strength 0.15
  11. Mark A. Carlson · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.